Drug Information

Drug General Information
Drug ID
D03REA
Former ID
DNC009120
Drug Name
5-Methoxy-3-(2-methoxybenzyl)-2H-chromen-2-one
Drug Type
Small molecular drug
Indication Discovery agent Investigative [530009]
Structure
Download
2D MOL

3D MOL
Formula
C18H16O4
Canonical SMILES
COC1=CC=CC=C1CC2=CC3=C(C=CC=C3OC)OC2=O
InChI
1S/C18H16O4/c1-20-15-7-4-3-6-12(15)10-13-11-14-16(21-2)8-5-9-17(14)22-18(13)19/h3-9,11H,10H2,1-2H3
InChIKey
PUMXCXWQMAPHFQ-UHFFFAOYSA-N
PubChem Compound ID
44592117
Target and Pathway
Target(s) Cannabinoid receptor 1 Target Info Inhibitor [530009]
Cannabinoid receptor 2 Target Info Inhibitor [530009]
KEGG Pathway Rap1 signaling pathway
Neuroactive ligand-receptor interaction
Retrograde endocannabinoid signalinghsa04080:Neuroactive ligand-receptor interaction
PANTHER Pathway Endogenous cannabinoid signaling
Pathway Interaction Database N-cadherin signaling events
Reactome Class A/1 (Rhodopsin-like receptors)
G alpha (i) signalling eventsR-HSA-373076:Class A/1 (Rhodopsin-like receptors)
G alpha (i) signalling events
WikiPathways GPCRs, Class A Rhodopsin-like
Small Ligand GPCRs
BDNF signaling pathway
GPCR ligand binding
GPCR downstream signaling
GPCRs, OtherWP455:GPCRs, Class A Rhodopsin-like
References
Ref 530009Bioorg Med Chem. 2009 Apr 1;17(7):2842-51. Epub 2009 Feb 21.Synthesis and pharmacological evaluation of coumarin derivatives as cannabinoid receptor antagonists and inverse agonists.
Ref 530009Bioorg Med Chem. 2009 Apr 1;17(7):2842-51. Epub 2009 Feb 21.Synthesis and pharmacological evaluation of coumarin derivatives as cannabinoid receptor antagonists and inverse agonists.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.